Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial.
Mitra SoltaniMohammad-Javad Hosseinzadeh-AttarMahsa RezaeiElham AlipoorAli Vasheghani-FarahaniMehdi YaseriSeyed Mahdi RezayatPublished in: Trials (2024)
Iranian Registry of Clinical Trials (IRCT20131125015536N8), June 19, 2019.
Keyphrases
- clinical trial
- risk factors
- double blind
- sleep quality
- phase ii
- coronary artery
- coronary artery disease
- placebo controlled
- physical activity
- depressive symptoms
- phase iii
- mental health
- study protocol
- open label
- aortic stenosis
- randomized controlled trial
- heart failure
- aortic valve
- transcatheter aortic valve replacement